This four day program will incorporate data supporting guideline-based recommendations and recent advances regarding therapeutic options for patients with malignant solid tumor disorders.
Learning Objectives
• Describe the pathogenesis, diagnostic evaluation and therapeutic modalities
available for common malignant hematological diseases
• Describe the pathogenesis, diagnostic evaluation and therapeutic modalities available for common solid tumor malignancies
• Integrate new therapeutic and diagnostic approaches into clinical practice as appropriate
• Manage and evaluate the bleeding and clotting patient